Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists

Matthew D. Morin, Ying Wang, Brian T. Jones, Lijing Su, Murali M R P Surakattula, Michael Berger, Hua Huang, Elliot K. Beutler, Hong Zhang, Bruce Beutler, Dale L. Boger

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Herein, we report studies leading to the discovery of the neoseptins and a comprehensive examination of the structure-activity relationships (SARs) of this new class of small-molecule mouse Toll-like receptor 4 (mTLR4) agonists. The compounds in this class, which emerged from screening an α-helix mimetic library, stimulate the immune response, act by a well-defined mechanism (mouse TLR4 agonist), are easy to produce and structurally manipulate, exhibit exquisite SARs, are nontoxic, and elicit improved and qualitatively different responses compared to lipopolysaccharide, even though they share the same receptor.

Original languageEnglish (US)
Pages (from-to)4812-4830
Number of pages19
JournalJournal of Medicinal Chemistry
Volume59
Issue number10
DOIs
StatePublished - May 26 2016

Fingerprint

Toll-Like Receptor 4
Structure-Activity Relationship
Libraries
Lipopolysaccharides
Mouse Tlr4 protein

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Morin, M. D., Wang, Y., Jones, B. T., Su, L., Surakattula, M. M. R. P., Berger, M., ... Boger, D. L. (2016). Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists. Journal of Medicinal Chemistry, 59(10), 4812-4830. https://doi.org/10.1021/acs.jmedchem.6b00177

Discovery and Structure-Activity Relationships of the Neoseptins : A New Class of Toll-like Receptor-4 (TLR4) Agonists. / Morin, Matthew D.; Wang, Ying; Jones, Brian T.; Su, Lijing; Surakattula, Murali M R P; Berger, Michael; Huang, Hua; Beutler, Elliot K.; Zhang, Hong; Beutler, Bruce; Boger, Dale L.

In: Journal of Medicinal Chemistry, Vol. 59, No. 10, 26.05.2016, p. 4812-4830.

Research output: Contribution to journalArticle

Morin, MD, Wang, Y, Jones, BT, Su, L, Surakattula, MMRP, Berger, M, Huang, H, Beutler, EK, Zhang, H, Beutler, B & Boger, DL 2016, 'Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists', Journal of Medicinal Chemistry, vol. 59, no. 10, pp. 4812-4830. https://doi.org/10.1021/acs.jmedchem.6b00177
Morin, Matthew D. ; Wang, Ying ; Jones, Brian T. ; Su, Lijing ; Surakattula, Murali M R P ; Berger, Michael ; Huang, Hua ; Beutler, Elliot K. ; Zhang, Hong ; Beutler, Bruce ; Boger, Dale L. / Discovery and Structure-Activity Relationships of the Neoseptins : A New Class of Toll-like Receptor-4 (TLR4) Agonists. In: Journal of Medicinal Chemistry. 2016 ; Vol. 59, No. 10. pp. 4812-4830.
@article{a37ef76720f04acc8da71ff852afc3b9,
title = "Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists",
abstract = "Herein, we report studies leading to the discovery of the neoseptins and a comprehensive examination of the structure-activity relationships (SARs) of this new class of small-molecule mouse Toll-like receptor 4 (mTLR4) agonists. The compounds in this class, which emerged from screening an α-helix mimetic library, stimulate the immune response, act by a well-defined mechanism (mouse TLR4 agonist), are easy to produce and structurally manipulate, exhibit exquisite SARs, are nontoxic, and elicit improved and qualitatively different responses compared to lipopolysaccharide, even though they share the same receptor.",
author = "Morin, {Matthew D.} and Ying Wang and Jones, {Brian T.} and Lijing Su and Surakattula, {Murali M R P} and Michael Berger and Hua Huang and Beutler, {Elliot K.} and Hong Zhang and Bruce Beutler and Boger, {Dale L.}",
year = "2016",
month = "5",
day = "26",
doi = "10.1021/acs.jmedchem.6b00177",
language = "English (US)",
volume = "59",
pages = "4812--4830",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - Discovery and Structure-Activity Relationships of the Neoseptins

T2 - A New Class of Toll-like Receptor-4 (TLR4) Agonists

AU - Morin, Matthew D.

AU - Wang, Ying

AU - Jones, Brian T.

AU - Su, Lijing

AU - Surakattula, Murali M R P

AU - Berger, Michael

AU - Huang, Hua

AU - Beutler, Elliot K.

AU - Zhang, Hong

AU - Beutler, Bruce

AU - Boger, Dale L.

PY - 2016/5/26

Y1 - 2016/5/26

N2 - Herein, we report studies leading to the discovery of the neoseptins and a comprehensive examination of the structure-activity relationships (SARs) of this new class of small-molecule mouse Toll-like receptor 4 (mTLR4) agonists. The compounds in this class, which emerged from screening an α-helix mimetic library, stimulate the immune response, act by a well-defined mechanism (mouse TLR4 agonist), are easy to produce and structurally manipulate, exhibit exquisite SARs, are nontoxic, and elicit improved and qualitatively different responses compared to lipopolysaccharide, even though they share the same receptor.

AB - Herein, we report studies leading to the discovery of the neoseptins and a comprehensive examination of the structure-activity relationships (SARs) of this new class of small-molecule mouse Toll-like receptor 4 (mTLR4) agonists. The compounds in this class, which emerged from screening an α-helix mimetic library, stimulate the immune response, act by a well-defined mechanism (mouse TLR4 agonist), are easy to produce and structurally manipulate, exhibit exquisite SARs, are nontoxic, and elicit improved and qualitatively different responses compared to lipopolysaccharide, even though they share the same receptor.

UR - http://www.scopus.com/inward/record.url?scp=84971595222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971595222&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.6b00177

DO - 10.1021/acs.jmedchem.6b00177

M3 - Article

C2 - 27050713

AN - SCOPUS:84971595222

VL - 59

SP - 4812

EP - 4830

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 10

ER -